Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Biomacromolecules|February 14, 2014
Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative studyAdriana Trapani, Claudio Palazzo, Marialessandra Contino, et al.
Journal of Medicinal Chemistry|October 23, 2020
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and NeurodegenerationGiuseppe Felice Mangiatordi, Francesca Intranuovo, Pietro Delre, et al.
European Journal of Medicinal Chemistry|December 13, 2021
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effectFrancesca S Abatematteo, Philip D Mosier, Mauro Niso, et al.
Chemmedchem|November 11, 2015
Stereoselective Modulation of P-Glycoprotein by Chiral Small MoleculesAlessia Carocci, Alessia Catalano, Francesco Turi, et al.
Chemmedchem|April 13, 2022
Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4-Substituted Quinazoline DerivativesLaura Braconi, Elisabetta Teodori, Marialessandra Contino, et al.
Bioorganic & Medicinal Chemistry|February 16, 2008
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulatorsNicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, et al.
European Journal of Medicinal Chemistry|August 13, 2023
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversersLaura Braconi, Silvia Dei, Marialessandra Contino, et al.
Journal of Medicinal Chemistry|October 21, 2022
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer CellsLaura Braconi, Elisabetta Teodori, Chiara Riganti, et al.
European Journal of Medicinal Chemistry|April 1, 2026
Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancerLeyre Lopez-Aguileta, Endika Martín-Encinas, Birgitta R Knudsen, et al.
Bioorganic Chemistry|August 17, 2025
New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivativesDominik Koszelewski, Ryszard Ostaszewski, Arleta Zaremba, et al.
Pageof 12